Hakamäki T, Rajala T, Lehtonen A
Department of Medicine, Turku City Hospital, Turku, Finland.
Int J Clin Pharmacol Ther. 1998 Jul;36(7):367-9.
Orthostatic hypotension is often associated with patients suffering from Parkinson's disease. Only few studies have been published about the ambulatory blood pressure in patients with Parkinson's disease. Fludrocortisone has been used in management of orthostatic hypotension. This study was made to determine the Circadian rhythm of blood pressure in healthy elderly people, in Parkinson's disease patients without orthostatic hypotension and Parkinson's disease patients with fludrocortisone medication for orthostatic hypotension. Ambulatory 24-hour blood pressure recordings were made in 20 elderly Parkinson's disease patients and 21 healthy elderly persons. Eight of the Parkinson's disease patients were on fludrocortisone (Florinef) therapy because of orthostatic hypotension. The mean daytime systolic blood pressure of Parkinson's disease patients without fludrocortisone was 123 mmHg and the mean nighttime systolic blood pressure was 121 mmHg. There was no significant difference between daytime and nighttime systolic blood pressure (Figure 1). Diastolic blood pressure in this group was significantly higher during the day (68 mmHg) than at night (63 mmHg) (Figure 2). The daytime blood pressure of control patients was 135/74 mmHg and at night 127/69 mmHg (Figures 1, 2). The blood pressure of Parkinson's disease patients with fludrocortisone was higher at night (156/83 mmHg) than during the day (134/77 mmHg) (Figures 1, 2). The daytime and nighttime systolic and diastolic blood pressure was significantly lower by non-fludrocortisone Parkinson patients than the blood pressure of fludrocortisone Parkinson patients (Figures 1, 2).
The Parkinson's disease patients were non-dippers and with fludrocortisone the blood pressure was higher at night than on day. On day, the blood pressure of the Parkinson's disease patients with fludrocortisone elevated to the level of controls.
体位性低血压常与帕金森病患者相关。关于帕金森病患者动态血压的研究发表较少。氟氢可的松已用于体位性低血压的治疗。本研究旨在确定健康老年人、无体位性低血压的帕金森病患者以及使用氟氢可的松治疗体位性低血压的帕金森病患者的血压昼夜节律。对20例老年帕金森病患者和21例健康老年人进行了24小时动态血压记录。其中8例帕金森病患者因体位性低血压接受氟氢可的松(Florinef)治疗。未使用氟氢可的松的帕金森病患者白天平均收缩压为123 mmHg,夜间平均收缩压为121 mmHg。白天和夜间收缩压无显著差异(图1)。该组患者白天舒张压(68 mmHg)显著高于夜间(63 mmHg)(图2)。对照组患者白天血压为135/74 mmHg,夜间为127/69 mmHg(图1、2)。使用氟氢可的松的帕金森病患者夜间血压(156/83 mmHg)高于白天(134/77 mmHg)(图1、2)。未使用氟氢可的松的帕金森病患者白天和夜间的收缩压和舒张压显著低于使用氟氢可的松的帕金森病患者(图1、2)。
帕金森病患者血压昼夜节律异常,使用氟氢可的松后夜间血压高于白天。白天,使用氟氢可的松的帕金森病患者血压升高至对照组水平。